Guided Therapeutics, Inc. (GTHP)

Guided Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 17, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30	10	8	15	8	4
Market Cap Growth	184.17%	17.63%	-43.03%	84.30%	101.40%	789.61%
Enterprise Value	34	15	13	18	17	10
Last Close Price	0.35	0.15	0.15	0.30	0.58	0.30
PS Ratio	170.46	1395.66	84.75	1121.44	97.66	38.51
PB Ratio	-5.37	-2.00	-2.18	-5.06	-1.45	-0.36
EV/Sales Ratio	192.65	2134.23	129.38	1364.13	210.72	96.70
Debt / Equity Ratio	-0.43	-0.44	-0.51	-0.78	-0.53	-0.41
Net Debt / Equity Ratio	-0.41	-0.36	-0.36	0.02	-0.41	-0.39
Net Debt / EBITDA Ratio	-1.22	-0.84	-0.50	0.02	-0.96	-4.10
Net Debt / FCF Ratio	-2.10	-1.58	-0.78	0.03	-1.40	-2.25
Asset Turnover	0.17	0.01	0.04	0.01	0.05	0.08
Inventory Turnover	0.11	0.01	0.11	0.14	0.10	-
Quick Ratio	0.01	0.06	0.12	0.48	0.12	0.02
Current Ratio	0.12	0.19	0.29	0.62	0.29	0.10
Return on Assets (ROA)	-111.85%	-86.48%	-67.47%	-77.07%	-87.09%	-51.98%
Return on Capital Employed (ROCE)	34.60%	44.10%	86.60%	221.80%	64.60%	13.80%
Earnings Yield	-9.24%	-24.74%	-42.01%	-29.78%	-26.17%	-7.10%
FCF Yield	-3.66%	-11.45%	-21.02%	-10.36%	-20.30%	-47.77%
Buyback Yield / Dilution	-31.78%	-12.14%	-57.30%	-142.99%	-24.24%	-226.07%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.